We found a sharper rise in classical hallmarks of AD progression, such as an increment in Tau phosphorylation (39) and the expression of proteins involved in APP processing such as cathepsin D (65) across the analysis of the four different brain areas. The gene discussed is APP; the disease is Alzheimer disease.